Irritable bowel syndrome in developing countries - A disorder of civilization or colonization?

Neurogastroenterology and Motility

Volumn 17, Issue 3, 2005, Pages 317-324

  Gwee, K A ^a,b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b GLENEAGLES HOSPITAL   (Singapore)

Author keywords

Asia; Epidemiology; Gender; Hygiene hypothesis; Pathogenesis; Symptoms

Indexed keywords

ASIA; DEFECATION; DEVELOPING COUNTRY; DIETARY INTAKE; EDUCATION; GASTROENTERITIS; HUMAN; HYGIENE; IRRITABLE COLON; MENTAL STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; SOCIAL STATUS; SYMPTOMATOLOGY;

CULTURE; DEVELOPING COUNTRIES; HUMANS; IRRITABLE BOWEL SYNDROME;

EID: 20044364384     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2005.00627.x     Document Type: Review

References (70)

1. Jones R, Lydeard S. Irritable bowel syndrome in the general population. Br Med J 1992; 304: 87-90.
2. Talley NJ, Zinmeister AR, Dyke CV, Melton LJ. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927-34.
3. Harvey RF, Salih SY, Read AE. Organic and functional disorders in 2000 gastroenterology outpatients. Lancet 1983; 1: 632-4.
4. Switz DM. What the gastroenterologist does all day. Gastroenterology 1976; 70: 1048-50.
5. Walker ARP, Segal I. Epidemiology of noninfective intestinal diseases in various ethic groups in South Africa. Israel J Med Sci 1979; 15: 309-13.
6. Painter NS, Burkitt DP. Diverticular disease of the colon: a deficiency disease of western civilization. Br Med J 1971; 2: 450-454.
7. Danivat D, Tankeyoon M, Sriratanaban A. Prevalence of irritable bowel syndrome in a non-western population. Br Med J 1988; 296: 1710.
8. Drossman DA, Sandler RS, Mckee DC, Lovitz AJ. Bowel patterns among subjects not seeking health care: use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 1982; 83: 529-34.
9. Kwan CPA, Hu H-CW, Chan YK, Yeung YW, Lai STT, Yuen H. Prevalence of irritable bowel syndrome in Hong Kong. J Gastronterol Hepatol 2002; 17: 1180-1186.
10. Gwee KA, Wee S, Wong ML, Png JCD. The prevalence, symptom characteristics and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol 2004; 99: 924-31.
11. Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther 2004; 19: 1217-1224.
12. Kumano H, Kaiya H, Yoshiuchi K, Yamanaka G, Sasaki T, Kuboki T. Comorbidity of irritable bowel syndrome, panic disorder and agoraphobia in a Japanese representative sample. Am J Gastroenterol 2004; 99: 370-5.
13. Lee OY, Lee SH, Yoon BC, et al. Prevalence and characteristics of irritable bowel syndrome symptoms in Korea. Korean J Gastrointest Motil 2001; 7: 104 (abstract).
14. Hoseini ASLMK, Amra B. Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol 2003; 22: 215-6.
15. Pan GZ, Lu S, Meiyun KE, Han SM, Guo HP, Fang XC. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by the cluster sampling. Chin Med J 2000; 113: 35-39.
16. Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in Mumbai. Indian J Gastroenterol 2001; 20: 103-6.
17. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria, are the new Rome 2 criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000; 95: 3176-83.
18. Hungin APS, Whorwell PJ, Tack J, Mearins F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17: 643-650.
19. Thompson WG, Irvine EJ, Pare P et al. Functional disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002; 47: 225-35.
20. Mearin F, Badia X, Balboa A. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome 2 versus previous criteria in a general population. Scand J Gastroenterol 2001; 36: 1155-61.
21. Hillila MT, Farkkila MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther 2004; 20: 339-45.
22. Wen BZ, Pang QY. Functional bowel disorders in apparently healthy Chinese. Chinese J Epidemiol 1988; 9: 345-9.
23. Schlemper RJ, Van Der WSD, Van den broucke JP, Biemond I, Lamers CB. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in the Netherlands and Japan. Scand J Gastroenterol 1993; 200: 33-41.
24. Olubuyide IO, Olawuyi F, Fasanmade AA. A study of irritable bowel syndrome diagnosed by manning criteria in an African population. Dig Dis Sci 1995; 40: 983-5.
25. Tan YM, Goh KL, Muhidayah R, Ooi CL, Salem O. Prevalence of irritable bowel syndrome in young adult Malaysians: a survey among medical students. J Gastroenterol Hepatol 2003; 18: 1412-6.
26. Lu CL, Chen CY, Lang HC et al. Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population. Aliment Pharmacol Ther 2003; 18: 1159-69.
27. Ji SW, Park H, Choi JP, Lee TH, Lee DY, Lee SI. Validation of Rome II criteria for functional gastrointestinal disorders in Korean patients. Korean J Gastroenterol 2003; 41: 183-9.
28. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93: 1816-22.
29. Kang JY, Ho KY, Yeoh KG, Guan R. Chronic upper abdominal pain due to duodenal ulcer and other structural and functional causes: its location and nocturnal occurrence. J Gastroenterol Hepatol 1996; 11: 515-9.
30. Kang JY, Tay HH, Guan R. Chronic upper abdominal pain: site and radiation in various structural and functional disorders and the effect of various foods. Gut 1992; 33: 743-8.
31. Thompson WG, Longstreth GF, Drossman DA et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 (suppl. II): 1143-7.
32. Mathur AK, Tandon BN, Prakash OM. Irritable Colon Syndrome a clinical and laboratory study. J Indian Med Assoc 1966; 46: 651-5.
33. Pimparkar BD. Irritable Colon Syndrome. J Indian Med Assoc 1970; 54: 95-105.
34. Bordie AK. Functional disorders of the colon. J Indian Med Assoc 1972; 58: 451-6.
35. Thompson WG. Irritable bowel syndrome: pathogenesis and management. Lancet 1993; 341: 1569-72.
36. Masud MA, Hasan M, Khan AKA. Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern and health care seeking behavior. Am J Gastroenterol 2001; 96: 1547-52.
37. Gwee KA, Graham JC, McKendrick MW et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-3.
38. Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53: 1096-101.
39. Talley NJ, Phillips SF, Melton LJ. Diagnostic value of the manning criteria in irritable bowel syndrome. Gut 1990; 31: 77-81.
40. Smith RC, Greenbaum DS, Vancouver JB. Gender differences in manning criteria in the irritable bowel syndrome. Gastroenterology 1991; 100: 591-5.
41. Houghton LA, Jackson NA, Whorwell PJ, Moriss J. Do male sex hormones protect from irritable bowel syndrome. Am J Gastroenterol 2000; 95: 2296-2300.
42. Miller V, Whittaker K, Morris JA, Whorwell PJ. Gender and irritable bowel syndrome: the male connection. J Clin Gastroenterol 2004; 38: 558-60.
43. Drossman DA, Li Z, Andruzzi E, Temple RD. US household survey of functional gastrointestinal disorders, Prevalence, sociodemography and health impact. Dig Dis Sci 1993; 38: 1569-80.
44. Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol 2004; 99: 1572-8.
45. Mendall MA, Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome. Eur J Gastroenterol Hepatol 1998; 10: 59-62.
46. Hasler WL, Schoenfeld P. Systematic review: abdominal and pelvic surgery in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17: 997-1005.
47. Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004; 126: 1665-73.
48. Talley NJ. Unnecessary abdominal and back surgery in irritable bowel syndrome: time to stem the flood now? Gastroenterology 2004; 126: 1899-903.
49. Chaudhary NA, Truelove SC. The irritable colon syndrome; a study of the clinical features, predisposing causes and prognosis in 130 cases. Q J Med 1962; 31: 307-22.
50. Harvey RF, Brown AM, Mauad EC. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet 1987; 1: 963-5.
51. Steinle EW, Vandermolen RL, Silbergleit A, Cohen MM. Impact of laparoscopic cholecystectomy on indications for surgical treatment of gallstones. Surg Endosc 1997; 11: 933-5.
52. Ross IN, Jayakumar CR. Asymptomatic cholelithiasis and the incidence of gallstone disease. Singapore Med J 1987; 28: 314-7.
53. Luke GN, Amayo EO. Irritable bowel syndrome in Kenyans. E Afr Med J 2002; 79: 360-3.
54. Francis CY, Whorwell PJ. Bran and irritable bowel syndrome: time for reappraisal. Lancet 1994; 344: 39-40.
55. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in 2 populations in Iran. Eur J Gastroenterol Hepatol 1995; 7: 427-33.
56. Alan Jones V, McLaughlin P, Shorthouse M et al. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet 1985; 2: 1115-7.
57. Senewiratne B, Thambipillai S, Perera H. Intestinal Lactase deficiency in Ceylon (Sri Lanka). Gastroenterology 1977; 2: 1257-9.
58. Bolin TD, Davis AE, Seah CS et al. Lactose intolerance in Singapore. Gastroenterology 1970; 59: 76-84.
59. Rodriguez LAG, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. Br Med J 1999; 318: 565-6.
60. Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44: 400-6.
61. Spiller RC, Jenkins D, Thomley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-11.
62. Gwee KA, Collins SM, Read NW et al. Increased rectal mucosal expression of interleukin 1B in recently acquired post-infectious irritable bowel syndrome. Gut 2003; 52: 523-6.
63. Chadwick VS, Chen WX, Shu D et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 1778-83.
64. Collins SM. A case for immunological basis for irritable bowel syndrome. Gastroenterology 2002; 122: 2078-80.
65. Stewart GT. Post-dysenteric colitis. Br Med J 1950; I: 405-9.
66. Anand AC, Reddy PS, Saiprasad GS, Kher SK. Does non-dysenteric intestinal amoebiasis exist? Lancet 1997; 349: 89-92.
67. Nanda R, Anand BS, Baveja U. Entamoeba histolytica cyst passers: clinical features and outcome in untreated subjects. Lancet 1984; ii: 301-3.
68. Sinha P, Ghoshal UC, Choudhuri G, Naik S, Ayyagari A, Naik SR. Does Entamoeba histolytica cause irritable bowel syndrome? Indian J Gastroenterol 1997; 16: 130-3.
69. Collins SM, Barbara G. East meets West: infection, nerves, and mast cells in the irritable bowel syndrome. Gut 2004; 53: 1068-9.
70. Read NW. Overview of irritable bowel syndrome. Eur J Gastroenterol Hepatol 1994; 6: 457-549.